Given that the accumulation of the Aβ peptide in the brain in Alzheimer's disease appears to be the result of a defect in clearance, rather than elevated production of the peptide [44], it is important to understand the contribution of α2M to the clearance of the Aβ peptide in greater detail. Here, A2M is linked to early-onset autosomal dominant Alzheimer disease.